Interestingly, it is reported that 88% of castration-resistant PCa (CRPC) bone metastases express prostatic acid phosphatase (PAP) in bone metastasis and there exists no significant difference between the osteoblastic and osteolytic lesions [16]. Here, ACP3 is linked to posterior cortical atrophy.